product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
Mouse anti PI-3 Kinase p85 Subunit Alpha
catalog :
MCA1167G
quantity :
0.2 mg
price :
394 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
U5
reactivity :
human, mouse, rat, bovine
application :
western blot, immunoprecipitation
more info or order :
image
image 1 :
Bio-Rad MCA1167G image 1
Jurkat Whole Cell lysate probed with Mouse anti PI-3 Kinase p85 Alpha subunit (MCA1167G)
product information
Entity Type :
Monoclonal Antibody
Entity Category :
Antibodies
ProductCode :
MCA1167G
Description :
Mouse anti PI-3 Kinase p85 Subunit Alpha
Specificity :
PI-3 Kinase p85 Subunit Alpha
TargetSpecies :
Bovine
Host :
Mouse
Format :
Purified
Isotypes :
IgG1
Applications :
WB,IP,C
ApplicationTypes :
Western Blotting,Immunoprecipitation,Immunohistology - Frozen
Cross Reactivities :
Human,Monkey,Mouse,Rat
Clone :
U5
Quantity :
0.2 mg
Quantity Value :
0.2
Quantity Type :
mg
GO Accessions :
GO:0043125,GO:0005158,GO:0005159,GO:0005943,GO:0008286,GO:0046326,GO:0035014,GO:0043560,GO:0046854,GO:0048009,GO:0090004,GO:0001953,GO:0006468,GO:0016303,GO:0030183,GO:0030335,GO:0043066,GO:0045671,GO:0005545,GO:0007173,GO:0008543,GO:0014065,GO:0019903,GO:0048015,GO:0030168,GO:0031295,GO:0043559,GO:0044419,GO:0048011,GO:0050852,GO:0050900,GO:0060396,GO:0005886,GO:0001878,GO:0001934,GO:0005161,GO:0005516,GO:0005625,GO:0005634,GO:0006006,GO:0030971,GO:0007584,GO:0008022,GO:0042493,GO:0009750,GO:0010040,GO:0010459,GO:0010628,GO:0046935,GO:0019717,GO:0019901,GO:0019904,GO:0022408,GO:0030331,GO:0031625,GO:0032355,GO:0032570,GO:0033574,GO:0043200,GO:0043548,GO:0043551,GO:0045471,GO:0045663,GO:0045768,GO:0045776,GO:0045861,GO:0048662,GO:0051117,GO:0051219,GO:0051591,GO:0070848,GO:0071398,GO:0071445,GO:0071548
GOTerms :
ErbB-3 class receptor binding,insulin receptor binding,insulin-like growth factor receptor binding,1-phosphatidylinositol-4-phosphate 3-kinase, class IA complex,insulin receptor signaling pathway,positive regulation of glucose import,phosphatidylinositol 3-kinase regulator activity,insulin receptor substrate binding,phosphatidylinositol phosphorylation,insulin-like growth factor receptor signaling pathway,positive regulation of establishment of protein localization in plasma membrane,negative regulation of cell-matrix adhesion,protein phosphorylation,1-phosphatidylinositol-3-kinase activity,B cell differentiation,positive regulation of cell migration,negative regulation of apoptosis,negative regulation of osteoclast differentiation,1-phosphatidylinositol binding,epidermal growth factor receptor signaling pathway,fibroblast growth factor receptor signaling pathway,phosphatidylinositol 3-kinase cascade,protein phosphatase binding,phosphatidylinositol-mediated signaling,platelet activation,T cell costimulation,insulin binding,interspecies interaction between organisms,nerve growth factor receptor signaling pathway,T cell receptor signaling pathway,leukocyte migration,growth hormone receptor signaling pathway,plasma membrane,response to yeast,positive regulation of protein phosphorylation,platelet-derived growth factor receptor binding,calmodulin binding,soluble fraction,nucleus,glucose metabolic process,receptor tyrosine kinase binding,response to nutrient,protein C-terminus binding,response to drug,response to fructose stimulus,response to iron(II) ion,negative regulation of heart rate,positive regulation of gene expression,1-phosphatidylinositol-3-kinase regulator activity,synaptosome,protein kinase binding,protein domain specific binding,negative regulation of cell-cell adhesion,estrogen receptor binding,ubiquitin protein ligase binding,response to estradiol stimulus,response to progesterone stimulus,response to testosterone stimulus,response to amino acid stimulus,phosphatidylinositol 3-kinase binding,regulation of phosphatidylinositol 3-kinase activity,response to ethanol,positive regulation of myoblast differentiation,positive regulation of anti-apoptosis,negative regulation of blood pressure,negative regulation of proteolysis,negative regulation of smooth muscle cell proliferation,ATPase binding,phosphoprotein binding,response to cAMP,response to growth factor stimulus,cellular response to fatty acid,cellular response to protein stimulus,response to dexamethasone stimulus
Uniprot Accessions :
P23727,P27986,P26450,Q63787
Gene :
PIK3R1,Pik3r1,PIK3R1,Pik3r1
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=282307, http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=18708, http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=5295, http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=25513
Entity Formats :
Purified
UNSPSC :
41116161
Concentration :
IgG concentration 1.0mg/ml
Product Form :
Purified IgG - liquid
PriceGBP :
281
PriceEUR :
394
PriceUSD :
394 USD
PriceCHF :
429
PriceSEK :
4295
PriceNOK :
4316
PriceDKK :
2938
more info or order :
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.